Status:
COMPLETED
Ergocalciferol in Chronic Kidney Disease
Lead Sponsor:
Saint Louis VA Medical Center
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18-80 years
Brief Summary
To examine the effect of ergocalciferol treatment on 25-hydroxyvitamin D and PTH levels in patients with CKD stage 3 and 4
Eligibility Criteria
Inclusion
- Patient with CKD stage 3 or 4 whose 25-hydroxyvitamin D levels are below 30 ng/ml and plasma intact PTH levels \>70 pg/ml.
Exclusion
- Patients who are on any form of active vitamin treatment
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00411294
Last Update
December 13 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Louis VA Medical Center
St Louis, Missouri, United States, 63104